Post

New research · Endocrinology
European journal of haematology · 23h
Cohort studyEuropean journal of haematology · 2026

Diabetic Patients With Newly Diagnosed Chronic Myeloid Leukemia: TKI Choice and Early Adverse Events. A Real-Life Survey Within the Italian Chronic Myeloid Leukemia Network.

S Russo, I Capodanno, M Tiribelli … R Latagliata
Read paper
EndocrinologyCohort study

Diabetic patients with chronic myeloid leukemia have lower major molecular response at 12 months.

Diabetic Patients With Newly Diagnosed Chronic Myeloid Leukemia: TKI Choice and Early Adverse Events. A Real-Life Survey Within the Italian Chronic Myeloid Leukemia Network.

S Russo et al. · European journal of haematology · 2026
Background

Limited data are available regarding patients with newly diagnosed chronic myeloid leukemia (CML) and concomitant diabetes mellitus (DM).

Methods

Hence, we retrospectively analyzed 2149 patients with newly diagnosed chronic phase (CP) CML to compare clinical characteristics, choice of frontline therapy, early adverse events, and molecular responses between patients with or without DM.

55.9%
Results
vs. 68.1%
Diabetic patients had lower major molecular response at 12 months (55.9% vs 68.1%).
More results

Among this cohort of 2149 patients, 241 patients (11.2%) had DM at CML diagnosis.

Discontinuation by the 12th month occurred in 24.2% of diabetic patients versus 19.4% of nondiabetics (p = 0.031), mainly for hematologic toxicity.

More results

Among diabetic patients, a trend toward better molecular responses was observed in patients receiving metformin (p = 0.068).

“
Conclusion

In conclusion, DM represents a clinically meaningful comorbidity in newly diagnosed CML-CP, and seems to define a subgroup with distinct features, influencing both treatment decisions and early outcomes.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Case-control
AUC = 0.94
CXCL9 levels accurately distinguish acute myeloid leukemia that resists treatment from remission
Cohort Study
AUC 0.939
Neutrophil-to-lymphocyte ratio is excellent at predicting who will get lung problems after bypass surgery
Guideline
>95%
most Hairy Cell Leukemia patients have a specific gene change causing their cancer
AI / Informatics
10.92%
Paroxysmal nocturnal haemoglobinuria was diagnosed in high-risk patients referred for testing by AI screening
Cohort Study
49%
Nearly half of patients had problems 30 days after spleen removal for blood cancer
Cohort Study
OR = 1.33
Higher FT4 levels are associated with 1.33 times higher odds of prevalent stroke.
Cohort Study
OR: 0.89
GLP-1RA users had slightly lower odds of Hodgkin's lymphoma than DPP-4i users
Cohort Study
OR 3.95
flexible sigmoidoscopy makes it almost 4 times more likely to find gastrointestinal GvHD